Lissa A. Goldenstein
Plus aucun poste en cours
Profil
Lissa A.
Goldenstein was the founder who founded Auxogyn, Inc. in 2008 and held the titles of President, Chief Executive Officer & Director.
She was also the President & Chief Executive Officer of Argonaut Technologies, Inc. from 2001 to 2005.
Ms. Goldenstein was the President & Chief Executive Officer of Verinata Health, Inc. and a Director at OtisMed Corp.
She was the Senior Vice President at Molecular Simulations, Inc. from 1998 to 2000.
Ms. Goldenstein received her undergraduate degree from The Pennsylvania State University in 1978.
Anciens postes connus de Lissa A. Goldenstein
Sociétés | Poste | Fin |
---|---|---|
Argonaut Technologies, Inc.
Argonaut Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Argonaut Technologies, Inc. develops, manufactures, and markets products that enable chemists to use high speed parallel synthesis in the development of new drugs | President | 03/06/2005 |
Molecular Simulations, Inc.
Molecular Simulations, Inc. Packaged SoftwareTechnology Services Molecular Simulations, Inc. is a provider of predictive modeling software. The company is based in San Diego, CA and has subsidiaries in the United States. The company was founded by Stephen L. Mayo. Molecular Simulations was acquired by BIOVIA, Inc., part of Dassault Systèmes SA from April 30, 2014 on June 12, 1998 for $119.85 million. | Corporate Officer/Principal | 01/08/2000 |
OtisMed Corp.
OtisMed Corp. Packaged SoftwareTechnology Services Part of Stryker Corp., OtisMed Corp. is a company that provides software solutions for joint replacement clinical problems. The company is based in Alameda, CA. OtisMed was acquired by Stryker Corp. on November 10, 2009. | Directeur/Membre du Conseil | - |
Auxogyn, Inc.
Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Fondateur | - |
Verinata Health, Inc.
Verinata Health, Inc. Medical/Nursing ServicesHealth Services Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA. | President | - |
Formation de Lissa A. Goldenstein
The Pennsylvania State University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 5 |
---|---|
Molecular Simulations, Inc.
Molecular Simulations, Inc. Packaged SoftwareTechnology Services Molecular Simulations, Inc. is a provider of predictive modeling software. The company is based in San Diego, CA and has subsidiaries in the United States. The company was founded by Stephen L. Mayo. Molecular Simulations was acquired by BIOVIA, Inc., part of Dassault Systèmes SA from April 30, 2014 on June 12, 1998 for $119.85 million. | Technology Services |
Argonaut Technologies, Inc.
Argonaut Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Argonaut Technologies, Inc. develops, manufactures, and markets products that enable chemists to use high speed parallel synthesis in the development of new drugs | Commercial Services |
Verinata Health, Inc.
Verinata Health, Inc. Medical/Nursing ServicesHealth Services Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA. | Health Services |
OtisMed Corp.
OtisMed Corp. Packaged SoftwareTechnology Services Part of Stryker Corp., OtisMed Corp. is a company that provides software solutions for joint replacement clinical problems. The company is based in Alameda, CA. OtisMed was acquired by Stryker Corp. on November 10, 2009. | Technology Services |
Auxogyn, Inc.
Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Health Technology |